Cris Figueroa Villalba, MD

354 posts

Cris Figueroa Villalba, MD banner
Cris Figueroa Villalba, MD

Cris Figueroa Villalba, MD

@crischufv

🇦🇷 Internist, Lab Med, TM/apheresis MD|🩸passion: ECMO TM | #IMG @UnivAustral & @yale Alumni | @uwlabmedpath Faculty | 🙌Emotional investor @hellogoodlabs

Seattle, WA Katılım Ekim 2020
436 Takip Edilen194 Takipçiler
Sabitlenmiş Tweet
Cris Figueroa Villalba, MD
Switching from ACT to antiXa (minimum 0.25 U/mL) for monitoring heparin was associated with reduction in ECMO circuit changes, a more stable heparin therapy and less diagnostic phlebotomy volumes with Cost reduction #ECMO #COVID19 #ICU #ELSO @SCCM @CritCareMed
Cris Figueroa Villalba, MD tweet mediaCris Figueroa Villalba, MD tweet media
English
4
1
10
0